Nebulizers Market Share and Size Analysis by 2031

Nebulizers Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Jet Nebulizers, Ultrasonic Nebulizers, and Mesh Nebulizers), Application (COPD, Asthma, Cystic Fibrosis, and Others), End User (Hospitals and Clinics, Emergency Center, and Home Care Setting), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America)

Publication Month : Mar 2024

  • Report Code : TIPTE100001066
  • Category : Medical Device
  • Status : Data Released
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

[Research Report] The nebulizers market was valued at US$ 815.88 million in 2023 and is expected to reach US$ 1315.57 million by 2031; it is estimated to record a CAGR of 6.2% during 2023–2031.

Market Insights and Analyst View:

The nebulizers market forecast is derived on the basis of findings from various secondary and primary research sources.

A nebulizer is a device used to deliver various medicines to help control breathing problems such as wheezing and loosen lung secretions. It converts liquid medicine into fine droplets, which are then inhaled through a mask or mouthpiece through which the medicine can enter directly into the lungs. Unlike other inhalers, nebulizers use an air compressor powered by electricity from an outlet.

Drivers and Restraints Affecting Nebulizers Market Growth

Home healthcare devices have become increasingly popular in recent years, owing to advancements in technology and miniaturization of products. This has led to a rise in adoption of home healthcare devices. Additionally, the growing number of elderly people, the high incidence of CRD, and the rising cost of healthcare services and hospital stays have resulted in a growing preference for treating patients in home care settings. Home healthcare is an affordable alternative to expensive hospital stays due to the availability of compact, portable, and patient-friendly nebulizers that are ideal for home use, coupled with technological innovations to reduce noise and improve functionality. Additionally, there is a wide range of drugs available in nebulized formulations, including long-acting beta2-agonists (LABAs), long-acting muscarinic receptor antagonists, steroids, antibiotics, and mucolytics. A few products recently launched in the market for home use are as follows:

  • In January 2023, Synergy Life Science, Inc. launched Nebi, a pocket-sized nebulizer that runs on batteries and is suitable for various applications.
  • In July 2021, HCmed Innovations received US Food and Drug Administration (FDA) approval for Pulmogine Vibrating Mesh Nebulizer. The device is portable and easy to use, making it a convenient solution for patients who require inhalation treatment.
  • In June 2020, Respira Technologies, Inc. launched its RespiRx drug delivery device platform. This novel platform is an ultra-portable handheld vibrating mesh nebulizer (VMN) for local and systemic treatment for various target indications, including asthma and COPD.

These developments have expanded the use of nebulizers beyond acute care settings in clinics or hospitals to home care settings.

However, lack of community awareness and perception of asthma, poor access to healthcare, strained healthcare systems, a lack of diagnostic tests, including spirometry, lack of training among healthcare providers, and the lack of non-implementation of asthma guidelines are all major factors that contribute to the underdiagnosis of asthma. Asthma underdiagnosis further leads to poor clinical outcomes for patients consuming incorrect medications for treating their condition, which in turn is expected to hamper the market growth. Despite the increasing prevalence of asthma across the world, there has been a lack of acceptance of the therapies, as people are more inclined toward ayurvedic and homemade medication. The guidelines for treating asthma and chronic obstructive pulmonary disease (COPD) have changed significantly. Inhaled corticosteroids (ICSs) alone or combined with a long-acting beta2-agonist (LABA) are the first-line treatment for asthma, while long-acting muscarinic antagonists alone or in combination with LABAs are the first-line treatment for COPD. Owing to such specific combinations, there is a rise in the cost of advanced and portable nebulizers. As per an article published in September 2020 by Pubmed Central, a study was carried out to evaluate the cost-effectiveness of intravenous methylprednisolone and nebulized budesonide in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in a practical environment. The study concluded that nebulized budesonide is not a cost-effective treatment as compared to intravenous methylprednisolone for patients with AECOPD in China. Therefore, the lack of early diagnosis and the high cost of nebulizing therapy hinder the nebulizers growth.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Nebulizers Market: Strategic Insights

nebulizer-market
Market Size Value inUS$ 815.88 million in 2023
Market Size Value byUS$ 1315.57 million by 2031
Growth rateCAGR of 6.2% from 2023 to 2031
Forecast Period2023-2031
Base Year2023
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Report Segmentation and Scope:

The “Global nebulizers market analysis to 2031” is a specialized and in-depth study focusing on the global market dynamics to help identify the key driving factors, future trends, and lucrative opportunities in the market that would, in turn, aid in identifying major revenue pockets. The report aims to provide an overview of the market with detailed market segmentation by type, application, and end-user. The scope of the nebulizers market report entails North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Segmental Analysis:

By type, the market is segmented into jet nebulizers, ultrasonic nebulizers, and mesh nebulizers. The jet nebulizers segment held the largest market share in 2022. The Mesh Nebulizers segment is projected to register the highest CAGR during 2023–2031. Jet nebulizers are affordable and easy-to-use devices that deliver medication in the form of aerosol. They are designed for one-time use, which eliminates the need for sterilization and reduces the risk of contamination. Jet nebulizers are commonly used during mechanical ventilation. The various application of these nebulizers in the treatment of CRD are propelling the jet nebulizers market size during the forecast period.

Nebulizers Market by Type – 2023 and 2031

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

The market, by application, is segmented into COPD, asthma, cystic fibrosis, and others. The COPD segment is anticipated to hold the largest nebulizer market share in 2023. The asthma segment is projected to grow with the highest CAGR during 2023–2031. COPD is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production, and wheezing. It's typically caused by long-term exposure to irritating gases or particulate matter, most often from cigarette smoke. People with COPD are at increased risk of developing heart disease, lung cancer, and a variety of other conditions. According to the World Health Organization (WHO), COPD is the third leading cause of death globally. With an increase in the burden of respiratory diseases, the demand for inhalation therapies is also increasing. Additionally, the shift in preference for home care treatments fuels the utilization of hand-held nebulizers for the management of COPD and asthma.

Based on end-user, the nebulizers market is segmented into hospitals and clinics, emergency centers, and home care settings. The hospitals and clinics segment held the largest share of the market in 2023 and is expected to register the highest CAGR from 2023 to 2030 owing to the medical availability of various types of nebulizers and the growing adoption rate of these devices in hospital settings.

Regional Outlook:

North America held the largest nebulizer market share in 2023. The US held the largest share of the market in this region in 2023, followed by Canada, owing to the increasing prevalence of COPD and asthma among people in the region. According to an article published in Merck Sharp & Dohme (MSD) Manual, ~16 million people suffer from COPD, which is a leading cause of death, claiming over 150,000 lives annually in the US. Other factors propelling the growth of the nebulizers market in North America include the introduction of advanced equipment in healthcare, increasing healthcare expenditures, and the presence of leading market players, including OMRON Healthcare, BD, and GE Healthcare in the region.

Industry Developments and Future Opportunities:

As per company press releases, a few initiatives taken by key players operating in the global nebulizers market are listed below:

  • In December 2021, Cipla Limited introduced an initiative to improve access to nebulization therapy for managing acute asthma in India's rural primary healthcare centers with its vast presence throughout the care continuum and a broad range of drug-device combinations and treatments.
  • In March 2021, PARI Pharma GmbH launched its LAMIRA Nebulizer System, which has been authorized to deliver ARIKAYCE (amikacin liposome inhalation suspension) in Japan. This system uses advanced aerosol delivery systems based on eFlow Technology and features a customized medication reservoir that can hold a full dose of 8.4 ml.
  • In March 2021, OMRON Healthcare, Inc. and the Asthma and Allergy Foundation of America (AAFA) collaborated to provide medical-grade nebulizers to support AAFA's advocacy and initiatives to spread awareness that aids the most vulnerable members of the asthma community.

Competitive Landscape and Key Companies:

OMRON Healthcare, Inc.; Koninklijke Philips N.V.; PARI GmbH; Vectura Group Ltd; Drive DeVilbiss International; Briggs Healthcare; GF Health Products, Inc.; GE Healthcare; Agilent Technologies, Inc.; Terumo Corporation; and Trudell Medical International are among the prominent companies profiled in nebulizers market report. These companies focus on new technologies, existing product advancements, and geographic expansions to meet the growing consumer demand worldwide.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type, Application, End User, and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the nebulizers market?

The nebulizers market majorly consists of the players, including Baxter; B. Braun Medical Inc.; BD; Cantel Medical; DaVita Inc.; Fresenius Medical Care; Medtronic; Nikkiso Co., Ltd.; Asahi Kasei Corporation; and Terumo Corporation.

What are the growth estimates for the nebulizers market till 2031?

The nebulizers market is expected to be valued at US$ 1315.57 million in 2031.

Which type segment dominates the nebulizers market?

Based on type, the market is segmented into jet nebulizers, ultrasonic nebulizers, and mesh nebulizers.

What are nebulizers?

A nebulizer is a device used to deliver various medicines to help control breathing problems such as wheezing and loosen lung secretions. It converts liquid medicine into fine droplets, which are then inhaled through a mask or mouthpiece through which the medicine can enter directly into the lungs. Unlike other inhalers, nebulizers use an air compressor powered by electricity from an outlet.

What was the estimated nebulizers market size in 2023?

The nebulizers market was valued at US$ 815.88 million in 2023.

What factors drive the nebulizers market?

Key factors driving the nebulizers market growth are the surging prevalence of chronic respiratory diseases and increasing demand for respiratory devices for home care settings are driving the growth of the market.

The List of Companies - Nebulizers Market

  1. OMRON Healthcare, Inc
  2.  Koninklijke Philips N.V.
  3. PARI GmbH
  4. Vectura Group Ltd
  5. Drive DeVilbiss International
  6. Briggs Healthcare
  7. GF Health Products, Inc.
  8. GE Healthcare
  9.  Agilent Technologies, Inc
  10.  Terumo Corporation
  11.  Trudell Medical International 

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Nebulizers Market